Literature DB >> 20719563

Does CPAP treatment in mild obstructive sleep apnea affect blood pressure?

Nattapong Jaimchariyatam1, Carlos L Rodriguez, Kumar Budur.   

Abstract

OBJECTIVES: Obstructive sleep apnea (OSA) is associated with significant cardiovascular (CV) morbidity. Continuous positive airway pressure (CPAP) is the standard treatment for moderate to severe OSA, resulting in a reduction in CV morbidity. No studies have compared CV outcomes between CPAP and no CPAP in mild OSA (5>or=AHI<15).
METHODS: Retrospective cohort study of subjects (age>or=18) with mild OSA diagnosed between 2004 and 2006. Subjects with a history of hypertension, angina, stroke and smoking were excluded. Subjects were stratified into two groups: CPAP (n=93) or no CPAP (n=162). The mean blood pressures (MBP) were compared 2 years after the diagnosis of OSA was established.
RESULTS: Unmatched for covariates (age, sex, BMI, neck circumference, AHI, arousal index and family h/o CV disorders), subjects with mild OSA on CPAP had a 1.97 point reduction, and no CPAP resulted in a 9.61 point elevation (p<0.0001) in MBP. With propensity score matching for covariates, the mean difference in MBP was -1.97 (95% CI: -14.03, -9.92; p<0.0001) with a sensitivity analysis of 2.646.
CONCLUSION: This study shows an elevation of the MBP in mild OSA patients who were not treated with CPAP. CPAP treatment in mild OSA patients decreased the MBP over a 2-year period.

Entities:  

Mesh:

Year:  2010        PMID: 20719563     DOI: 10.1016/j.sleep.2010.05.005

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  7 in total

Review 1.  Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-08-12       Impact factor: 3.996

Review 2.  Death by a thousand cuts in Alzheimer's disease: hypoxia--the prodrome.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-02-12       Impact factor: 3.911

3.  Common secondary causes of resistant hypertension and rational for treatment.

Authors:  Charles Faselis; Michael Doumas; Vasilios Papademetriou
Journal:  Int J Hypertens       Date:  2011-03-02       Impact factor: 2.420

4.  Comparison of cardiovascular co-morbidities and CPAP use in patients with positional and non-positional mild obstructive sleep apnea.

Authors:  Yi-Chih Huang; Chun-Yao Lin; Chou-Chin Lan; Yao-Kuang Wu; Chor-Shen Lim; Chun-Yao Huang; Hsuan-Li Huang; Kuan-Hung Yeh; Yu-Chih Liu; Mei-Chen Yang
Journal:  BMC Pulm Med       Date:  2014-09-26       Impact factor: 3.317

5.  The treatment of mild OSA with CPAP or mandibular advancement device and the effect on blood pressure and endothelial function after one year of treatment.

Authors:  Thais Moura Guimarães; Dalva Poyares; Luciana Oliveira E Silva; Gabriela Luz; Glaury Coelho; Cibele Dal Fabbro; Sergio Tufik; Lia Bittencourt
Journal:  J Clin Sleep Med       Date:  2021-02-01       Impact factor: 4.062

6.  Cardiac imageology changes in patients with mild obstructive sleep apnea without cardiovascular disease.

Authors:  Zuogeng Hong; Qiong Ou; Yilu Cheng; Yanxia Xu; Hongwen Fei; Hui Liu
Journal:  Sleep Breath       Date:  2021-06-29       Impact factor: 2.816

Review 7.  Effects of chronic obstructive pulmonary disease and obstructive sleep apnea on cognitive functions: evidence for a common nature.

Authors:  Georgia Andreou; Filippos Vlachos; Konstantinos Makanikas
Journal:  Sleep Disord       Date:  2014-02-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.